Cargando…
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy
Autores principales: | Cooles, Faye A.H., Anderson, Amy E., Lendrem, Dennis W., Norris, Julie, Pratt, Arthur G., Hilkens, Catharien M.U., Isaacs, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751729/ https://www.ncbi.nlm.nih.gov/pubmed/28987811 http://dx.doi.org/10.1016/j.jaci.2017.08.026 |
Ejemplares similares
-
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis
por: Cooles, Faye A. H., et al.
Publicado: (2018) -
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming
por: Cooles, Faye A H, et al.
Publicado: (2022) -
Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis
por: Harry, Rachel A, et al.
Publicado: (2010) -
A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease
por: Pratt, Arthur G, et al.
Publicado: (2012) -
Tolerogenic dendritic cells differentially modulate naïve and memory CD4(+ )T cells
por: Anderson, Amy E, et al.
Publicado: (2007)